Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
129M
-
Number of holders
-
243
-
Total 13F shares, excl. options
-
87.8M
-
Shares change
-
+8.91M
-
Total reported value, excl. options
-
$1.93B
-
Value change
-
+$197M
-
Put/Call ratio
-
0.25
-
Number of buys
-
147
-
Number of sells
-
-85
-
Price
-
$21.94
Significant Holders of NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) as of Q2 2019
281 filings reported holding NEO - NEOGENOMICS INC - Common Stock, $0.01 par value as of Q2 2019.
NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) has 243 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87.8M shares
of 129M outstanding shares and own 67.96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (14.9M shares), VANGUARD GROUP INC (8.17M shares), JANUS HENDERSON GROUP PLC (3.99M shares), EAGLE ASSET MANAGEMENT INC (2.7M shares), STATE STREET CORP (2.57M shares), BROWN ADVISORY INC (2.53M shares), CARILLON TOWER ADVISERS, INC. (2M shares), EMERALD ADVISERS, LLC (1.95M shares), EMERALD MUTUAL FUND ADVISERS TRUST (1.87M shares), and Granite Investment Partners, LLC (1.79M shares).
This table shows the top 243 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.